Pfizer insists that Novo Nordisk’s unsolicited offer to acquire Metsera is an effort from the Danish pharma to “suppress competition.” ...

And investors looking for corporations that fit the bill should strongly consider Novo Nordisk (NYSE: NVO) and Regeneron Pharmaceuticals (NASDAQ: REGN). Here's why these two drugmakers could be about ...

Pfizer Inc said on Monday it has filed a second lawsuit against its controlling shareholder, Metsera, and Novo Nordisk in a ...

Kimberly-Clark agrees to buy Tylenol maker Kenvue in a cash-and-stock deal valued at about $48.7 billion, including debt.